Previzion Aksyon Hansoh Pharmaceutical (3692)
Previzyon AI: 3692
AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.
Pri lor dernie 6 mwa
Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.
Debloke Premium🔒 Historik previzion
Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.
Debloke PremiumSou Konpayi Sa a
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).
